H. Stephen Kaye, University of California San Francisco, San Francisco, California. Joseph Caldwell ([email protected]), Brandeis University, Waltham, Massachusetts. Using health plan data, we ...

This article is the latest in the Health Affairs Forefront series, Provider Prices in the Commercial Sector, featuring analysis and discussion of physician, hospital, and other health care provider ...

Laurence C. Baker is a professor of health research and policy at Stanford University, in California, and a research associate at the National Bureau of Economic Research, in Cambridge, Massachusetts.

John Creighton Campbell ( [email protected]) is emeritus professor of political science at the University of Michigan in Ann Arbor. Naoki Ikegami is professor and chair of the Department of Health ...

(Editor’s note: The federal government has removed several web pages linked to in this brief. Where possible, links to archived versions have been inserted.) Data are the cornerstone of public health ...

In October 2021, a Pennsylvania judge denied the property tax exemption for three hospitals owned by a Pennsylvania hospital system, claiming that operations at the hospitals in question had become ...

Clinical development programs for new drugs include an array of research conducted both before and after a drug’s initial approval by the Food and Drug Administration (FDA). Post-approval clinical ...

Despite Medicaid’s importance as a payer and source of coverage for mental health care, relatively little is known about how prevalence, access, and quality might vary among Medicaid beneficiaries.

This article is the latest in the Health Affairs Forefront series, Provider Prices in the Commercial Sector, featuring analysis and discussion of physician, hospital, and other health care provider ...

The primary data sources for NP graduation numbers are from the annual Enrollment and Graduation In Baccalaureate and Graduate Programs in Nursing, reported by the American Association of Colleges of ...

The assured, consistent availability of pharmaceuticals is a cornerstone for patient wellbeing, effective treatment, and equal access to needed medical care. Pharmaceutical supply disruptions ...

So rare is bipartisan regulatory legislation in Congress, especially in health care, that when it occurs one must presume it is in response to prohibitive costs to society or a threat to patient ...